Contact
Please use this form to send email to PR contact of this press release:
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial
TO:
Please use this form to send email to PR contact of this press release:
Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial
TO: